MannKind Corporation (MNKD) Stock: Is Now The Time To Get Involved?
MannKind Corporation (NASDAQ: MNKD) has been a very interesting stock to watch since 2014, when the United States Food and Drug Administration (FDA) approved the company’s inhaled insulin known as Afrezza. Considering that there were no needles to be used and the insulin was a fast-acting, after-meals option, investors believed that the treatment would fly off … Read more